CIK 0001464521
- Non-accelerated filer
- Emerging growth company
Heartflow, Inc.
Sign in to watch- Ticker
- HTFL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 260506743
- Phone
- +1 650-241-1221
- Business address
- 135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
- Former names
- Cardiovascular Simulation, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,355,127
- in 11 filings, $16.4M under 10b5-1 plans
Net −$16,355,127. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | Rogers Campbell Chief Medical Officer | Exercise or conversion 10b5-1 | +12,328 | $8.33 | $103K | 83,511 |
| 2026-11-17 | Rogers Campbell Chief Medical Officer | Exercise or conversion 10b5-1 | +5,101 | $2.22 | $11K | 88,612 |
| 2026-11-17 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −24,188 | $46.39 | $1.1M | 64,424 |
| 2026-11-17 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −5,654 | $46.39 | $262K | 5,654 |
| 2026-11-17 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −6,503 | $46.39 | $302K | 6,503 |
| 2026-11-17 | Rogers Campbell Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −12,328 | 6,799 | ||
| 2026-11-17 | Rogers Campbell Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −5,101 | 60,581 | ||
| 2026-11-06 | Rogers Campbell Chief Medical Officer | Shares withheld for taxes | −2,270 | $52.40 | $119K | 71,183 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −5,654 | $55.01 | $311K | 11,308 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −6,503 | $55.01 | $358K | 13,006 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Exercise or conversion 10b5-1 | +12,329 | $8.33 | $103K | 92,285 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Exercise or conversion 10b5-1 | +5,101 | $2.22 | $11K | 97,386 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −23,933 | $55.01 | $1.3M | 73,453 |
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −12,329 | 19,127 | ||
| 2026-10-22 | Rogers Campbell Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −5,101 | 65,682 | ||
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −5,653 | $50.15 | $283K | 16,962 |
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −6,503 | $50.15 | $326K | 19,509 |
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Exercise or conversion 10b5-1 | +12,329 | $8.33 | $103K | 98,788 |
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Exercise or conversion 10b5-1 | +850 | $2.22 | $2K | 99,638 |
| 2026-09-18 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −19,682 | $50.15 | $987K | 79,956 |
Page 1 of 4 · 67 trades